Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M47,258Revenue (TTM) $M101,600Net Margin (%)2.7Altman Z-Score3.2
Enterprise Value $M55,718EPS (TTM) $4.2Operating Margin %4.8Piotroski F-Score8
P/E(ttm)18.1Beneish M-Score-2.8Pre-tax Margin (%)4.1Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %22.5Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %17.1Current Ratio0.7Lower Leverage y-yN
Price/Free Cash Flow9.8y-y EBITDA Growth Rate %21.0ROA % (ttm)5.3Higher Current Ratio y-yY
Dividend Yield %--PEG1.1ROE % (ttm)17.2Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M617ROIC % (ttm)10.6Gross Margin Increase y-yY

Gurus Latest Trades with ESRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ESRXDavid Dreman 2016-09-30 Reduce-0.69%$69.25 - $79.68
($74.78)
$ 76.713%Reduce -54.60%12,314
ESRXBarrow, Hanley, Mewhinney & Strauss 2016-09-30 Add0.3%$69.25 - $79.68
($74.78)
$ 76.713%Add 18.85%17,407,316
ESRXHOTCHKIS & WILEY 2016-09-30 Sold Out -0.25%$69.25 - $79.68
($74.78)
$ 76.713%Sold Out0
ESRXWallace Weitz 2016-09-30 Reduce-0.13%$69.25 - $79.68
($74.78)
$ 76.713%Reduce -4.40%1,000,693
ESRXChris Davis 2016-09-30 Reduce-0.11%$69.25 - $79.68
($74.78)
$ 76.713%Reduce -6.39%4,638,868
ESRXRobert Olstein 2016-09-30 Add0.1%$69.25 - $79.68
($74.78)
$ 76.713%Add 8.31%142,000
ESRXJoel Greenblatt 2016-09-30 Reduce-0.08%$69.25 - $79.68
($74.78)
$ 76.713%Reduce -9.47%871,757
ESRXMario Gabelli 2016-09-30 Reduce-0.05%$69.25 - $79.68
($74.78)
$ 76.713%Reduce -95.01%4,880
ESRXDodge & Cox 2016-09-30 Reduce-0.02%$69.25 - $79.68
($74.78)
$ 76.713%Reduce -1.30%21,410,369
ESRXArnold Van Den Berg 2016-09-30 Reduce-0.02%$69.25 - $79.68
($74.78)
$ 76.713%Reduce -1.50%96,155
ESRXKen Fisher 2016-09-30 Reduce$69.25 - $79.68
($74.78)
$ 76.713%Reduce -1.34%347,357
ESRXRichard Pzena 2016-09-30 Buy $69.25 - $79.68
($74.78)
$ 76.713%New holding3,507
ESRXCharles Brandes 2016-09-30 Add$69.25 - $79.68
($74.78)
$ 76.713%Add 0.13%2,129,437
ESRXArnold Van Den Berg 2016-06-30 Buy 1.24%$67.24 - $76.95
($73.45)
$ 76.714%New holding97,615
ESRXBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Add0.56%$67.24 - $76.95
($73.45)
$ 76.714%Add 49.88%14,646,371
ESRXDavid Dreman 2016-06-30 Add0.54%$67.24 - $76.95
($73.45)
$ 76.714%Add 74.94%27,122
ESRXHOTCHKIS & WILEY 2016-06-30 Reduce-0.23%$67.24 - $76.95
($73.45)
$ 76.714%Reduce -50.14%775,261
ESRXJoel Greenblatt 2016-06-30 Reduce-0.15%$67.24 - $76.95
($73.45)
$ 76.714%Reduce -16.87%962,979
ESRXChris Davis 2016-06-30 Reduce-0.06%$67.24 - $76.95
($73.45)
$ 76.714%Reduce -3.64%4,955,717
ESRXLeucadia National 2016-06-30 Sold Out -0.04%$67.24 - $76.95
($73.45)
$ 76.714%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ESRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ESRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Miller Steven BSr. VP & Chief Med. Officer 2016-11-09Sell21,798$75.022.25view
Anderson Phyllis S.Sr. VP & Ch. Marketing Officer 2016-11-09Sell642$74.742.64view
MYERS WOODROW A JRDirector 2016-09-14Sell12,036$70.48.96view
McGinnis Christopher AVP, Controller & Ch. Acct. Off 2016-09-12Sell1,785$70.778.39view
Neville EverettSenior VP, Supply Chain 2016-05-10Sell800$74.113.51view
MAC MAHON THOMAS PDirector 2016-04-29Sell5,482$73.933.76view
McGinnis Christopher AVP, Controller & Ch. Acct. Off 2016-03-10Sell579$68.5611.89view
Anderson Phyllis S.Sr. VP & Ch. Marketing Officer 2016-03-07Sell614$71.147.83view
Houston ChristineSenior VP, Operations 2016-03-01Sell8,721$71.557.21view
Neville EverettSenior VP, Supply Chain 2016-02-29Sell4,323$718.04view

Quarterly/Annual Reports about ESRX:

News about ESRX:

Articles On GuruFocus.com
Analysis of AmerisourceBergen's Dividend Increase Nov 17 2016 
Weitz Funds Comments on Express Scripts Nov 11 2016 
Weitz Balanced Fund 3rd Quarter Commentary Nov 11 2016 
Wally Weitz Comments on Express Scripts Nov 08 2016 
Wally Weitz's Partners Value Fund 3rd Quarter Commentary Nov 08 2016 
When Is the PEG Ratio Superior to the P/E Ratio? Part 2 Nov 03 2016 
Leith Wheeler Investment Funds 3rd Quarter Review Nov 01 2016 
Hell or High Water Oct 26 2016 
Novo Nordisk Is Being Ignored Oct 06 2016 
21 Questions With Peridot Capital Management's Chad Brand Sep 28 2016 

More From Other Websites
Express Scripts Earns Top Marks in 2017 Corporate Equality Index Dec 05 2016
Dreman Value’s Most Eye-Popping Moves of Q3 in Ford, Magna, More Dec 02 2016
Express Script CMO: Our goal is getting lowest net price... Dec 01 2016
Express Scripts Is One of the Most Powerful Players in Healthcare Nov 30 2016
Grey Owl Sees Large Upside For 3 High-Yield REITs; Bullish On 2 Other Stocks Nov 27 2016
After Sharp Q2 Fall, Hedge Fund Interest in Express Scripts Holding Company (ESRX) Rebounds in Q3 Nov 23 2016
A Pair Trade In U.S. Healthcare: Bullish on Centene, Neutral On Aetna Nov 14 2016
Express Scripts Holding Company Announces 2017 Financial Guidance Conference Call Nov 14 2016
Express Scripts Holding Company Announces 2017 Financial Guidance Conference Call Nov 14 2016
Weitz Funds Comments on Express Scripts Nov 11 2016
Weitz Balanced Fund 3rd Quarter Commentary Nov 11 2016
Should You Invest in International Game Technology (IGT), Express Scripts Holding Company (ESRX),... Nov 10 2016
The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics,... Nov 10 2016
Asian shares join Wall Street rally as Trump fears ease Nov 09 2016
Asian shares join Wall Street rally as Trump fears ease Nov 09 2016
ETF’s with exposure to Express Scripts Holding Co. : November 9, 2016 Nov 09 2016
Wally Weitz's Partners Value Fund 3rd Quarter Commentary Nov 08 2016
Wally Weitz Comments on Express Scripts Nov 08 2016
CVS cuts forecast after contract losses to Walgreens, shares dive Nov 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)